Market news

CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.

New research from The Cigna Group (NYSE: CI) finds that volunteering is associated with better health, stronger workplace engagement, and greater connection to community. According to the company's fifth annual Vitality in America report, people who volunteer are nearly twice as likely to report high vitality, a measure of how healthy, connected, and capable a person feels. The research also found that employees who participate in employer-supported volunteer activities are significantly more li

Cigna Group (CI) continues to draw attention after its recent close at US$288.90, with investors weighing modest return figures across the past week, month, and past 3 months against the insurer's broader long term track record. Recent trading has been more mixed for Cigna Group, with the share price slipping 0.4% on the day but still posting a 4.7% 7 day gain and a 3.5% year to date share price return. The 1 year total shareholder return of 0.4% and 5 year total shareholder return of 56.7%...

Everett disposed of 11% of his direct equity holdings under a pre-arranged Rule 10b5-1 trading plan, leaving a stake valued at $1.45 million.

Cigna Healthcare recently introduced an industry-first connected benefits experience that links medical and supplemental health coverage to simplify access to cash benefits for unexpected health events, with Medical with Smart Coverage slated to begin offering supplemental cash of up to US$7,000 per covered event from January 2027 for eligible mid-sized employer plans. This move directly addresses widespread gaps in Americans’ financial readiness for medical shocks and the underuse of...

CI has underperformed the broader market over the past year, despite analysts remaining moderately bullish on its future prospects.

CI's Smart Coverage links medical and supplemental benefits, offering up to $7,000 and automated claims for costly health events.

Katya Andresen says AI can make healthcare more conversational, proactive, and personal for Cigna's 185 million customers.

Cigna Healthcare®, the health benefits division of The Cigna Group (NYSE: CI), is introducing a new connected benefits experience that helps people pay for costs associated with unexpected or costly health events by bringing medical and supplemental health benefits together in a simpler, more personalized way.

UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.

Cigna Group stock reacts to TestMu Conference spotlight on AI and reliability Cigna Group (CI) is in focus after the company scheduled a presentation at the 5th TestMu Conference on August 19, 2026, featuring AI and automation engineering lead Nagarjun Adikesavan. The event highlights Cigna Group’s emphasis on quality and reliability in AI driven systems, which matters for investors who are watching how large health insurers apply automation to complex pharmacy and medical benefit...

Cigna Group stock has delivered a 44.4% gain over the past five years, yet the broader valuation checks still suggest the shares screen as undervalued at the recent price of US$277.51. With shorter term returns weaker, investors are left weighing a mixed share price history against a still supportive valuation read. Over five years, Cigna Group has returned 44.4%, which points to solid long term wealth creation despite more recent share price softness. Expectations for the company to keep...

CI's growth and shareholder returns are weighed against rising costs, medical expenses and debt, keeping investors neutral for now.

Cigna stock is a "Buy" as Accredo & AI-powered Pharmacy Forward drive EPS growth. Here's what investors need to know.

Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q2 health insurance providers earnings season.

Cigna Group has lagged the broader market despite consistent earnings performance, while analysts remain moderately optimistic about its future prospects.

Elizabeth Warren is backing a bipartisan bill to curb vertical integration in healthcare and lower costs for patients and drugs.

Investing.com -- Raymond James downgraded Cigna Group to Outperform from Strong Buy and lowered its price target to $320 from $350, saying the health insurer's valuation remains attractive but near-term catalysts are lacking as growth moderates and its pharmacy benefit management (PBM) business faces ongoing headwinds. The brokerage said Cigna operates in a mature market with slower growth than other names under its coverage and expects continued investments in the PBM transition, combined with

Cigna maintains a Buy rating as valuation remains deeply discounted despite steady earnings growth and raised guidance. Click here to read more on CI stock.

The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The Cigna Group reported second quarter net income of nearly $1.7 billion despite continued elevated medical costs dogging the entire health insurance industry.

The health company now expects full-year adjusted earnings of at least $30.45 per share, up 10 cents from its prior outlook

Cigna (CI) delivered earnings and revenue surprises of +2.64% and +0.18%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Cigna delivers an earnings and revenue beat as Cigna Healthcare fuels growth, while the company raises its 2026 EPS outlook despite higher pharmacy costs.

Health insurance company Cigna (NYSE:CI) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 6.8% year on year to $71.67 billion. Its non-GAAP profit of $7.78 per share was 2.4% above analysts’ consensus estimates.

Investing.com -- The Cigna Group (NYSE:CI) reported second-quarter earnings and revenue that exceeded analyst expectations, while raising its full-year outlook, though shares fell 1% premarket following the announcement.

Global health company The Cigna Group (NYSE: CI) today reported second quarter 2026 results, reflecting solid operational performance across its diversified portfolio of businesses.

Cigna Group (NYSE:CI) raised its full-year 2026 adjusted earnings outlook after reporting second-quarter results that management said exceeded expectations in both its Evernorth health services business and Cigna Healthcare insurance segment. The company reported second-quarter total revenue of $71

July 30 (Reuters) - Cigna on Thursday raised its annual profit forecast, after beating quarterly earnings estimates on growth in its pharmacy and specialty drug businesses.

Adjusted EPS of $7.78 beats expectations, leading to a full-year outlook increase to at least $30.45, as Specialty and Care Services surge 22%.